ARTICLE | Distillery Therapeutics
Neurology
January 31, 2018 10:10 PM UTC
Patient samples and mouse studies suggest promoting clearance of CDKN2A-positive senescent cells could help treat PD. In postmortem substantia nigra tissue samples from patients, levels of the cellula...
BCIQ Company Profiles
BCIQ Target Profiles
Cyclin dependent kinase inhibitor 2A (CDKN2A) (INK4a) (ARF) (p16INK4a)